Community

It was a party of international stature. More than 300 scientists from 27 countries dined and rubbed elbows in the J. Harper Poor Mansion in Manhattan, a three-story abode that in past years had welcomed the likes of President John F. Kennedy, comedian Jack Benny, and actress Marilyn Monroe. At the center of it all were the Krims, who had invited the droves of researchers into their home for a celebration to kick off an international workshop at Rockefeller University. The subject was interferon, a class of natural proteins associated with the immune system.

Across the world, conferencing software flicked open on computer screens. It was 8 a.m. in San Francisco, 11 a.m. in Frederick, 5 p.m. in Madrid, 11 p.m. in Hong Kong. The first day of the Third National Cancer Institute RAS Initiative Symposium was about to begin. Time zones notwithstanding, scientists and onlookers were tuning in from offices, studies, and living rooms to watch the livestream of the virtual event.

Block off the afternoon of September 1, 2021, in your calendar because the Technology Showcase is returning for its fifth year. The event will be fully virtual and, as always, feature exciting biomedical technologies, panels on important topics for industry stakeholders, and various poster pitches. New this year is an increased focus on the patient’s voice.

Behind the scenes in Frederick National Laboratory’s Scientific Publications, Graphics & Media department, illustrator Joe Meyer is making scientists’ cover dreams come true. While he’s professionally worked on illustrations for over two decades, about a third of that time focused on scientific images, Meyer has also worked on around 35 cover image designs over the last several years.

More than 20 of those designs have been selected as cover images. Meyer’s cover designs have been featured in various publications, including Cell Chemical Biology, Chemical Science, and Nature Chemical Biology.

Overcoming obstacles that caused the cancellation of the Student Science Jeopardy! Tournament last summer, Scientific Library staff used a virtual platform to hold the 14th annual tournament earlier this month.

At first, Meredith Yeager, Ph.D., thought there was a mistake in the data. She was examining the association between exposure to ionizing radiation after the 1986 Chernobyl power plant disaster and the frequency of exposed Ukrainians later passing radiation-driven genetic mutations to their children. Previous studies suggested that the children’s DNA should have contained multiple such mutations. It didn’t.

The Spring Research Festival came to Fort Detrick this year without its signature massive tent, the home of a sprawling equipment expo with dozens of booths. It came without audiences in auditoriums or gatherings around scientific posters. The community didn’t circulate between buildings for events. On the surface, it may have seemed that the festival didn’t come at all. But after being cancelled last year due to the pandemic, the annual two-day event did indeed return in a virtual format.

A potato, puffin, pineapple, orange, and lemon stood behind small electronic scoreboards. White text, read aloud by the Scientific Library’s Alan Doss, materialized on a blue field above their heads. “Every action has an equal and opposite…”

George Vande Woude, Ph.D., former director of the Advanced Bioscience Laboratories–Basic Research Program at what is now NCI at Frederick, passed away in April. He was known for being a prudent leader and an outstanding scientist (he and his laboratory discovered the MET oncogene in 1984), as well as for his vibrant personality and seemingly limitless energy.

The past year for Ligia Pinto, Ph.D., and her staff has been full of pressure and remote meetings at all hours of the day and night. It’s also been one of partnerships and progress. Pinto heads the Vaccine, Immunity, and Cancer Directorate, the group at the Frederick National Laboratory that’s leading the national SARS-CoV-2 Serological Sciences Network (SeroNet). At this time last year, her laboratories, which specialized in human papillomavirus, antibody science, and serology, had just been asked to help the Food and Drug Administration evaluate the quality of the new SARS-CoV-2 antibody tests that were flooding the market.